NCT06717724

Brief Summary

§ The goal of this clinical trial is to assess the effect of periarticular procaine injections combined with physical therapy on joint pain in individuals 65 and older suffering from osteoarthritis of the hip or the knee. The main question it aims to answer is: Is procaine effective in decreasing joint pain? Researchers will compare procaine injections combined with physical therapy to physical therapy only to evaluate whether or not procaine helps decrease joint pain. Participants will: Undergo procaine periarticular injections and physical therapy Assess their symptoms and pain using scales and tests provided

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
203

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Feb 2024

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 8, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 8, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 30, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 5, 2024

Completed
Last Updated

December 5, 2024

Status Verified

February 1, 2024

Enrollment Period

4 months

First QC Date

November 30, 2024

Last Update Submit

November 30, 2024

Conditions

Keywords

procaineinfiltrationgeriatric assessmentperiarticular injectionsgerovital h3geriatric depressionhip osteoarthritisknee osteoarthritisana aslanphysical therapyactivities of daily living (ADL)instrumental activities of daily living (IADL)

Outcome Measures

Primary Outcomes (1)

  • Pain Levels

    Change in Pain Level on Visual Analogue Scale (VAS)

    Baseline to Day 10

Secondary Outcomes (3)

  • Functional Improvement

    Baseline to Day 10

  • ADL and IADL Scores

    Baseline to Day 10

  • Geriatric Depression Scale

    Baseline to Day 10

Study Arms (2)

Experimental

EXPERIMENTAL

Participants in the experimental arm received daily periarticular injections of procaine complex solution (5 ml containing 100 mg procaine hydrochloride) over a 10-day period. All injections were administered using sterile technique. Prior to treatment, sensitivity to procaine hydrochloride was assessed with a subcutaneous test dose (0.5 ml)

Drug: Periarticular Procaine Injection (PAPI)Other: Kinesiotherapy

Control

ACTIVE COMPARATOR

Participants received only physical therapy without procaine injections.

Other: Kinesiotherapy

Interventions

Participants will receive periarticular 5 ml procaine injections targeting painful joints for 10 consecutive days alternating between knee- and/or hip joints

Experimental

Kinesiotherapy

ControlExperimental

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Adults aged 65 and older diagnosed with knee or hip osteoarthritis per the American College of Rheumatology criteria. Must exhibit radiographic evidence of OA and experience persistent joint pain

You may not qualify if:

  • Individuals with Alzheimer's, severe depression, cancer, or other severe health conditions, and those with allergies to procaine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

"Sf. Luca" Chronic Disease Hospital

Bucharest, Romania

Location

MeSH Terms

Conditions

Osteoarthritis, HipOsteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Sorina Maria Aurelian

    "Carol Davila" University of Medicine and Pharmacy Geriatrics and Gerontology Clinic, "Sf. Luca" Chronic Disease Hospital Bucharest

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants are divided into an experimental group that receives the basic treatment combined with the intervention and one control group that receives the basic treatment
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 30, 2024

First Posted

December 5, 2024

Study Start

February 8, 2024

Primary Completion

June 8, 2024

Study Completion

October 30, 2024

Last Updated

December 5, 2024

Record last verified: 2024-02

Locations